Undescended Testes
5
1
1
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
20.0%
1 terminated out of 5 trials
50.0%
-36.5% vs benchmark
20%
1 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Could miRNAs be Used as Markers for Distinguishing Undescended Testicles From Retractile Testicles
Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants
Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel
"Comparison of USG-Guided Caudal Versus Ilioinguinal/Iliohypogastric Nerve Block for Pediatric Inguinal Surgeries"
Role of Laparoscopy in Management of Non-palpable Undescended Testis : Assuit University Experience